No Data
No Data
Onconetix Names Interim CFO Karina Fedasz as Interim CEO
Onconetix Claims Validation of Prostate Cancer Test Proclarix in Danish Cohort
Onconetix Announces New Clinical Data for Its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Onconetix Announces Leadership Changes and New Appointments
Express News | Onconetix Inc: Approved an Increase to Board's Size From Five to Six Members